Market Vectors® Pharmaceutical ETF (PPH)

73.27
Delayed Data
As of May 27
 +0.90 / +1.24%
Today’s Change
57.00
Today|||52-Week Range
73.46
+14.00%
Year-to-Date

Investment Objective

The investment seeks to replicate as closely as possible, before fees and expenses, the price and yield performance of the Market Vectors ® US Listed Pharmaceutical 25 Index (the "Pharmaceutical Index"). The fund normally invests at least 80% of its total assets in securities that comprise the fund's benchmark index. The Pharmaceutical Index is comprised of common stocks and depositary receipts of U.S. exchange-listed companies in the pharmaceutical sector. Such companies may include medium-capitalization companies and foreign companies that are listed on a U.S. exchange. It is non-diversified.

No recent news for Market Vectors® Pharmaceutical ETF.

Performance

1 month+2.45% 3 years+28.85%
3 months+6.61% 5 years--
1 year+24.18% Since inception+25.94%
Data through 05/28/2015

Quote Details

Previous close$72.37
Open day’s range-- – --
Net asset value (NAV)73.25 (05/27/2015)
Daily volume49,428
Average volume (3 months)85,506
Data as of 05/27/2015

Peer Comparisonvs. Health ETFs

 PPHCategory
Performance 5-yr return--+22.89%
Expense Gross exp ratio0.43%0.47%
Risk 5 year sharpe ratio--1.46
Net assets$377.9M$1.7B
Average market cap$98.9B$35.4B
Average P/E27.224.6
Dividend / Share--0.21%

Competitors

XLV Health Care Select Sector SPDR® Fund
VHT Vanguard Health Care Index Fund ETF Shar...
RYH Guggenheim S&P 500® Equal Weight Health...

Holdings

Top 5 Sectors
Portfolio weighting
Business service --
Consumer goods --
Consumer service --
Energy --
Financial service --
Top 10 Holdings
Portfolio weighting
NVS Novartis9.57%
JNJ Johnson & Johnson8.33%
PFE Pfizer6.62%
NVO Novo Nordisk5.87%
SNY Sanofi5.16%
MRK Merck5.05%
-- 4.90%
ABBV AbbVie4.83%
GSK GlaxoSmithKline4.76%
ACT Actavis4.67%

To view my watchlist

Not a member yet?

Sign up now for a free account

Partner Financial Offers